MedMain, a company that develops and provides the pathology AI analysis solution "PidPort," has been selected as a J-Startup company by the Ministry of Economy, Trade and Industry and is a startup with high expectations for the future. Dr. Shinpaku interviewed Mr. Osamu Iizuka, the founder and CEO of MedMain. In this article, we will share the contents of the interview.